Public policy statement on buprenorphine for opiate dependence and withdrawal.
D002047:Buprenorphine / Q000191:economics* / Q000627:therapeutic use*; D035082:Federal Government; D006801:Humans; D009292:Narcotic Antagonists / Q000191:economics* / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011640:Public Policy; D012955:Societies, Medical; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D014481:United States
D009292:Narcotic Antagonists; D002047:Buprenorphine